A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer

✍ Scribed by B. Kaufman; R. Weitzen; A. Goldfarb; N. Ephrat; I. Kuchuk; T. Golan; I. Wolf; R. Elia

• Book ID: 119598227
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 62 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70735-3